Rare diseases
Investigational molecules
Locations
Back to the Netherlands119 clinical trials in Amersfoort, The Netherlands across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure
The NetherlandsStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
The NetherlandsStudy of Pembrolizumab and Chemotherapy for Patients with HR+/HER2- Advanced Breast Cancer
The NetherlandsStudy on Benralizumab for Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with Frequent Exacerbations
The NetherlandsStudy of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups
The NetherlandsStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
The NetherlandsStudy of Lutetium (177Lu) Oxodotreotide, Carboplatin, Etoposide, and Atezolizumab in Newly Diagnosed Extensive Stage Small Cell Lung Cancer Patients
The NetherlandsA study to evaluate the efficacy and safety of zenagamtide in people with obesity
The NetherlandsEfficacy and Safety Evaluation of Belantamab Mafodotin Versus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients
The NetherlandsA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
The NetherlandsLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
The NetherlandsStudy of PF-07220060 and Letrozole for Adults with HR-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, including studies for breast cancer, prostate cancer, and leukemia. Research encompasses targeted therapies and novel drug combinations.
Emphasis on personalized treatment approaches and improving patient outcomes through targeted therapies.
Research initiatives exploring cardiovascular disease management and prevention, including innovative treatments for reducing major cardiovascular events and improving patient outcomes.
Focus on developing new therapeutic approaches for cardiac conditions and preventive strategies.
Clinical investigations into dementia and related conditions, studying new approaches to manage behavioral symptoms and improve patient care outcomes.
Dedicated to understanding and treating complex neurological conditions with innovative therapies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
